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Abstract
Gene-cell therapy is a new step for the treatment of different human disorders including central
nervous system degenerative diseases. In this review we focused on the last challenges in the
field of human umbilical cord blood mononuclear cells transplantation - An attempt to support
neuronal cells survival and to stimulate the neuroregeneration. As a potential therapy for the
treatment of neurodegenerative diseases we reviewed the latest advances in gene modification
of human umbilical cord blood mononuclear cells as a novel tool for the effective delivery of
neuroprotective factors and growth factors in the injured or degenerative areas of the central
nervous system under pathological conditions. The main topic of this review is the potential
therapy  of  the  amyotrophic  lateral  sclerosis  -  The  progressive  neurodegenerative  disorder
affecting  primarily  upper  and  lower  motoneurons  -  by  using  genetically  modified  human
umbilical cord blood mononuclear cells. The results from the up-to-date experiments indicated
the opportunity to obtain differentiated macrophages, endothelial cells, or astrocytes from the
genetically modified human umbilical cord blood mononuclear cells after their transplantation in
the mouse model of the amyotrophic lateral sclerosis. Taken together, these data build the high-
capacity platform for the supporting of degenerating neurons, structural and functional recovery
of the brain and spinal cord after trauma, ischemia and other neurodegenerative disorders. ©
Human stem cells institute, 2013.
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